- Home
- MITK vs FHTX Comparison
MITK vs FHTX Comparison
Compare MITK & FHTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MITK
- FHTX
- Stock Information
- Founded
- MITK 1983
- FHTX 2015
- Country
- MITK United States
- FHTX United States
- Employees
- MITK N/A
- FHTX N/A
- Industry
- MITK Computer peripheral equipment
- FHTX Medicinal Chemicals and Botanical Products
- Sector
- MITK Technology
- FHTX Health Care
- Exchange
- MITK Nasdaq
- FHTX Nasdaq
- Market Cap
- MITK 440.3M
- FHTX 513.7M
- IPO Year
- MITK N/A
- FHTX 2020
- Fundamental
- Price
- MITK $11.43
- FHTX $5.14
- Analyst Decision
- MITK Strong Buy
- FHTX Strong Buy
- Analyst Count
- MITK 4
- FHTX 5
- Target Price
- MITK $12.63
- FHTX $13.80
- AVG Volume (30 Days)
- MITK 833.9K
- FHTX 197.3K
- Earning Date
- MITK 12-16-2024
- FHTX 11-04-2024
- Dividend Yield
- MITK N/A
- FHTX N/A
- EPS Growth
- MITK N/A
- FHTX N/A
- EPS
- MITK 0.07
- FHTX N/A
- Revenue
- MITK $172,083,000.00
- FHTX $25,515,000.00
- Revenue This Year
- MITK $6.41
- FHTX N/A
- Revenue Next Year
- MITK $11.24
- FHTX $11.54
- P/E Ratio
- MITK $163.29
- FHTX N/A
- Revenue Growth
- MITK N/A
- FHTX N/A
- 52 Week Low
- MITK $7.35
- FHTX $2.70
- 52 Week High
- MITK $16.24
- FHTX $10.25
- Technical
- Relative Strength Index (RSI)
- MITK 75.15
- FHTX 27.35
- Support Level
- MITK $8.58
- FHTX $4.69
- Resistance Level
- MITK $11.56
- FHTX $5.70
- Average True Range (ATR)
- MITK 0.48
- FHTX 0.61
- MACD
- MITK 0.25
- FHTX -0.14
- Stochastic Oscillator
- MITK 95.64
- FHTX 16.24
About MITK Mitek Systems Inc.
Mitek Systems Inc is engaged in the development, sale, and service of proprietary software solutions related to mobile imaging. The firm is a software development company with expertise in artificial intelligence, and machine learning. It is serving more than 7,800 financial services organizations and leading marketplace and financial technology brands across the globe. Mitek's Mobile Deposit solution is used by consumers for mobile check deposits. The company's Mobile Verify verifies a user's identity online enabling organizations to build safer digital communities, whereas CheckReader enables financial institutions to automatically extract data from a check image received across any deposit channel - branch, ATM, RDC, and mobile.
About FHTX Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing it to identify, validate, and potentially drug targets within the system. The company is developing FHD-286, a selective, allosteric ATPase inhibitor, and FHD-609, a protein degrader, to treat hematologic cancers and solid tumors.